Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1 - PubMed (original) (raw)
Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1
J J Liepnieks et al. Biochim Biophys Acta. 1995.
Free article
Abstract
Serum amyloid A protein (SAA) is the plasma precursor for amyloid A protein (AA), the subunit protein in amyloid deposits of secondary or reactive amyloidosis. Several forms of acute phase SAA have been identified in human plasma. To elucidate whether one of these forms of SAA predominates in the formation of AA amyloid deposits, the amino acid sequence of the subunit protein in six cases of reactive amyloidosis was investigated. Minimal heterogeneity was present at the N-terminus as all samples started with residue 1, 2, or 3 of SAA. The C-terminus, however, was more heterogeneous with the AA protein in each case terminating at multiple sites from residue 58 to 84 of SAA. Since less than 20% of the AA protein in each case contained sequence past residue 67 of SAA, the sequence and recovery of tryptic peptides containing residues 52, 57, and 60 where human SAA1 and 2 differ was used to determine the relative amounts of SAA1 and 2 present. One sample contained only SAA1 sequence, four contained approx. 11% or less of SAA2 sequence, and the sixth contained 24-33% of SAA2 sequence. Thus, while five of the six AA samples contained both SAA1 and 2, the predominant form in all cases was SAA1. In three of the six cases, the protein defensin was isolated along with the AA protein from the fibrils. This may suggest neutrophil involvement in SAA processing to AA fibrils.
Similar articles
- Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.
Meek RL, Hoffman JS, Benditt EP. Meek RL, et al. J Exp Med. 1986 Mar 1;163(3):499-510. doi: 10.1084/jem.163.3.499. J Exp Med. 1986. PMID: 3950541 Free PMC article. - Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis.
Baba S, Takahashi T, Kasama T, Shirasawa H. Baba S, et al. Biochim Biophys Acta. 1992 Dec 10;1180(2):195-200. doi: 10.1016/0925-4439(92)90068-x. Biochim Biophys Acta. 1992. PMID: 1463770 - Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A.
Colón W, Aguilera JJ, Srinivasan S. Colón W, et al. Adv Exp Med Biol. 2015;855:117-34. doi: 10.1007/978-3-319-17344-3_5. Adv Exp Med Biol. 2015. PMID: 26149928 Review. - Secondary, AA, Amyloidosis.
Papa R, Lachmann HJ. Papa R, et al. Rheum Dis Clin North Am. 2018 Nov;44(4):585-603. doi: 10.1016/j.rdc.2018.06.004. Epub 2018 Sep 7. Rheum Dis Clin North Am. 2018. PMID: 30274625 Review.
Cited by
- Case report: Rapid development of amyloid A amyloidosis in temporal arteritis with SAA1.3 allele; An unusual case of intestinal amyloidosis secondary to temporal arteritis.
Yoshida S, Matsumoto H, Temmoku J, Shakespear N, Kiko Y, Kikuchi K, Sumichika Y, Saito K, Fujita Y, Matsuoka N, Asano T, Sato S, Suzuki E, Watanabe H, Ohira H, Migita K. Yoshida S, et al. Front Immunol. 2023 Mar 21;14:1144397. doi: 10.3389/fimmu.2023.1144397. eCollection 2023. Front Immunol. 2023. PMID: 37026007 Free PMC article. - Signal peptide stabilizes folding and inhibits misfolding of serum amyloid A.
Wu JL, Chen YR. Wu JL, et al. Protein Sci. 2022 Dec;31(12):e4485. doi: 10.1002/pro.4485. Protein Sci. 2022. PMID: 36309973 Free PMC article. - Revisiting misfolding propensity of serum amyloid A1: Special focus on the signal peptide region.
Haines MS, Ramirez E, Moore KBE, Fortin JS. Haines MS, et al. Biochem Biophys Rep. 2022 May 30;31:101284. doi: 10.1016/j.bbrep.2022.101284. eCollection 2022 Sep. Biochem Biophys Rep. 2022. PMID: 35664543 Free PMC article. - Role of Serum Amyloid A in Abdominal Aortic Aneurysm and Related Cardiovascular Diseases.
Shridas P, Patrick AC, Tannock LR. Shridas P, et al. Biomolecules. 2021 Dec 15;11(12):1883. doi: 10.3390/biom11121883. Biomolecules. 2021. PMID: 34944527 Free PMC article. Review. - The potential role of glycosaminoglycans in serum amyloid A fibril formation by in silico approaches.
Maszota-Zieleniak M, Danielsson A, Samsonov SA. Maszota-Zieleniak M, et al. Matrix Biol Plus. 2021 Jul 22;12:100080. doi: 10.1016/j.mbplus.2021.100080. eCollection 2021 Dec. Matrix Biol Plus. 2021. PMID: 34401710 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous